You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰格醫藥(03347.HK)擬成立合營以投資生命及健康產業
格隆匯 06-11 20:30

格隆匯6月11日丨泰格醫藥(03347.HK)宣佈,於2021年6月11日,公司與杭州市國有資本投資運營有限公司、杭州高新創業投資有限公司(統稱"合營方")及杭州泰瓏創業投資合夥企業(有限合夥)("杭州泰瓏")訂立意向書。

根據意向書,公司、杭州泰瓏及合營方擬於中國成立有限合夥企業,以投資生命及健康產業("基金")。建議基金規模為人民幣200億元,將由公司及杭州泰瓏分別出資人民幣98億元及人民幣2億元以及各合營方分別出資人民幣50億元。基金將重點投資創新醫療器械、生物醫藥、醫療服務、醫療信息化、數字療法及智能製造等企業("建議合作")。

另建議杭州泰瓏於基金註冊成立後擔任基金的管理人,並將成立策略投資委員會就投資及相關退出作出決策。基金擬運作12年,其中最初五年為投資期,而之後的五年則為退出期,最後兩年將用作任何投資無法及時退出情況下的緩衝期。

據悉,杭州市國有資本投資運營有限公司主要從事杭州市政府授權範圍內的國有資產管理、投資、投資管理及諮詢服務、資產管理及處置、股權管理及股權投資基金管理。杭州高新創業投資有限公司主要從事初創公司投資、提供投資諮詢服務及提供初創公司管理服務。

公吿稱,透過投資基金,能夠利用公司強大的投資及融資平台,深化公司生物醫藥領域的佈局,促進優化上下游產業鏈,從而提升公司的核心競爭力。有關投資與公司的長期投資策略相輔相成,符合公司股東及公司的整體利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account